Parkinson's Disease

<p>Parkinson's disease (PD) is the second-most common neurodegenerative disease currently affecting more than 10 million people worldwide. There is currently no identified treatment and only symptomatic relief can be offered. The disease has clinical and pathological definitions through its cardinal motor manifestations and substantia nigra neuronal loss associated with intraneuronal Lewy bodies respectively. The molecular mechanisms that lead to neurodegeneration remain elusive. It is becoming increasingly apparent that genetic factors contribute to its complex pathogenesis with 90 loci from genome-wide association studies and many monogenic causes unraveled in the past years. The knowledge acquired from their protein products revealed pathways of neurodegeneration that Mendelian and sporadic Parkinsonism may share. These pathways include synaptic lysosomal mitochondrial and immune-mediated mechanisms of pathogenesis. This Special Issue Parkinson's Disease: Genetics and Pathogenesis collected 12 high-quality papers including 7 original research articles and 5 reviews that seek to deepen the knowledge of multiple aspects related to Parkinsonism.</p>